(Q38018253)

27 August 2017

title

Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment (English)

1 reference

27 August 2017

1 reference

Evi S Lianidou

1

1 reference

27 August 2017

Athina Markou

series ordinal

2

1 reference

27 August 2017

Areti Strati

series ordinal

3

1 reference

27 August 2017

language of work or name

1 reference

1 December 2012

1 reference

Cancer and Metastasis Reviews

27 August 2017

published in

1 reference

27 August 2017

volume

31

1 reference

27 August 2017

issue

3-4

1 reference

27 August 2017

page(s)

663-671

1 reference

27 August 2017

cites work

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating cancer cells and their clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

HER-2, notch, and breast cancer stem cells: targeting an axis of evil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating tumor cells as emerging tumor biomarkers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

HER2-positive circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Molecular biomarker analyses using circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Epithelial-to-mesenchymal transitions and circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Micrometastasis: detection methods and clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Detection of circulating tumor cells in peripheral blood of breast cancer patients during or after therapy using a multigene real-time RT-PCR assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

Molecular mechanisms of metastasis in breast cancer--clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9366-8

10.1007/S10555-012-9366-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1012745524

0 references

1 reference